Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GTF3C1 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of GTF3C1 mRNA | decreases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GTF3C1 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GTF3C1 mRNA | decreases expression | 20127859
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GTF3C1 mRNA | decreases expression | 19150397
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of GTF3C1 mRNA | affects expression | 12734012
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of GTF3C1 mRNA | decreases expression | 16239168
|
D003520 |
Cyclophosphamide |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of GTF3C1 mRNA | affects cotreatment|affects expression | 16322899
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with Cyclophosphamide] affects the expression of GTF3C1 mRNA | affects cotreatment|affects expression | 16322899
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of GTF3C1 mRNA | decreases expression | 18548127
|
D005996 |
Nitroglycerin |
Nitroglycerin results in increased expression of GTF3C1 mRNA | increases expression | 12102619
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GTF3C1 mRNA | increases expression | 18301758
|
D012643 |
Selenium |
Selenium results in increased expression of GTF3C1 mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.54 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.54 | 17418594 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.80 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.80 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.63 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.67 | 21441931 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.21 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.74 | 15014928 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.19 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.26 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.87 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.91 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.02 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.02 | 12006526 17388661 15093573 11325840 18323546 15136595 16978400 18234424 17020986 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.02 | 11325840 15692762 15994142 16096432 15567936 18628466 17426702 18695136 16322301 15136595 18382427 15939500 16115903 19526202 15993339 16264153 16595493 17369602 18234424 17983394 15668708 15634643 16826403 16935488 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.92 | 15721981 15673190 15700767 16227642 16050911 18705752 16097048 16011737 16124888 10355542 3786805 16192424 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.98 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
9.06 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
9.06 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
9.06 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
9.06 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
9.06 | 18059187 16023760 17876044 16234567 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.04 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
11.13 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
11.13 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
11.13 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.79 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.79 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.60 | 16731534 16242529 17329180 17007740 17351982 16455267 18627295 17924179 15476868 16952015 17519947 16612575 16651473 17974986 17131338 15792986 17308081 17928571 16269455 16364871 17382496 15811867 15505089 16278810 16109756 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.61 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.61 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.61 | 20889678 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
8.11 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.11 | 19176532 |
MESH:D003092 |
Colitis |
|
Selenium |
3.92 | 17936198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.16 | 17010015 18093676 10700343 10498854 17979934 18433785 18295254 12913760 12161096 15643279 18483878 16413132 16989017 16614059 18710439 12388444 11948286 18372110 16651033 15276878 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.94 | 11298694 12868966 2524372 18759878 11906362 8156756 14531868 8970840 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.61 | 3621924 2952479 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.16 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.25 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.36 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
12.36 | 1440618 16192314 8291058 7440962 9653073 18692083 6679447 18289764 9328219 9022650 11289319 18648102 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
12.36 | 3732212 4309450 7179309 7440962 3786805 16177239 15027814 21278145 10092053 17522070 10915739 16227642 7120509 19085960 11566570 2869522 6884620 15968718 6623471 9327722 15998439 19336974 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.36 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
12.36 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.75 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.59 | 12083418 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.52 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.33 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.35 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.34 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.34 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.34 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
8.04 | 12631006 16239168 15959796 19224547 17595544 61145 16045604 12795759 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.04 | 20131406 19236843 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.19 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.74 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.59 | 18705752 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.42 | 17150277 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.67 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.15 | 7505956 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.17 | 16376943 11014644 15172196 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
5.36 | 11554966 11284996 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.60 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.71 | 20471113 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.56 | 16495754 16330681 16879835 17888722 14766674 16244371 16244372 16707910 18006777 12587719 17875725 18674790 16144979 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
12.19 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
12.19 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
12.19 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.01 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.43 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.71 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
9.65 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
9.65 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.13 | 19176532 16221962 19772884 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.03 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.03 | 17606976 15147373 18501091 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.69 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.08 | 15034207 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.23 | 15338365 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.51 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.69 | 16517039 7193160 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.37 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.19 | 8074119 9022650 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.11 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.35 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.35 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.67 | 6582329 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.54 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.33 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.54 | 18172266 17802794 17296974 17008537 17658394 18587576 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.17 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.12 | 10052129 11830472 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.86 | 16239168 16943688 17334410 11408273 17174718 16221502 21278145 11903743 17157831 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.26 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.57 | 13678700 14716496 18395914 17698563 12632512 15925388 18418968 12389079 12667390 17922224 16192424 18277467 12445421 17714472 18187930 14620537 17525996 15931870 17640975 18472332 18156304 16638106 15876570 18376398 17766677 17823541 17631135 17557913 17721639 14748882 17900296 15730626 10355542 18412020 12741479 16136751 20821823 16015684 11481614 17708605 15052691 12632514 15893842 17805973 18263696 12445418 15650968 18006644 12958196 18251166 14724832 18210741 15996030 17481882 15959796 15370692 16033810 12898905 16027843 17869086 18205269 18420326 15057751 15338365 18705752 17976157 16116963 18395095 18279442 16011737 17944888 18054572 15123356 16248980 18317297 17761835 16097048 14512876 17565644 12546737 18429990 12609069 18339082 15818738 14716833 12649538 15362042 12666154 18166357 18472094 18481824 15673190 12586293 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.57 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.57 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.10 | 15720792 16964402 17285989 16246199 15830285 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.30 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.79 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.00 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.00 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
11.00 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.00 | 15890375 20007298 16377806 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.70 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.70 | 598648 6587162 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
14.70 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.70 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.54 | 20464547 18520028 18569708 20135361 18816296 6695378 17053015 20869020 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.54 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.14 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.14 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.71 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
9.30 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.30 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.70 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.42 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.42 | 15318939 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.30 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.94 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.42 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.42 | 15107826 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
4.85 | 3537620 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
5.25 | 14659530 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.61 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.27 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.94 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.86 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
9.86 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.86 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.98 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.98 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.59 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.59 | 18854779 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.59 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.91 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.10 | 15640375 16889571 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.98 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.39 | 8761367 15176712 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.39 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.04 | 12837982 8761367 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.44 | 8291058 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.23 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
9.23 | 6482804 4026338 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.86 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.19 | 3988306 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.20 | 15930896 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.71 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.22 | 11332152 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.62 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.64 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.33 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.06 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.33 | 17638057 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.86 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.13 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.13 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.13 | 15897917 16888761 18437689 16868541 16729912 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.13 | 16205645 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.32 | 16636934 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.36 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.46 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.09 | 15675481 15625365 17203757 17710206 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.37 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.94 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.94 | 16636934 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.97 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.97 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.70 | 17203757 16767912 15625365 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.67 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.21 | 12837982 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.54 | 7505956 6582329 6587162 1399818 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.54 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
16.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
16.25 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
16.25 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
16.25 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
16.25 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.36 | 17638931 17678736 16364871 17334414 |